Long-term survival of stage IV melanoma patients treated with a polyvalent, shed antigen, melanoma vaccine

被引：0
|
作者：
Laky, D
Shapiro, RL
Harris, MN
Roses, DF
Jacquotte, AZ
Reynolds, SR
Bystryn, J
机构：
[1] NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY USA
[2] NYU, Sch Med, Dept Surg, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 119卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
198
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [21] IMMUNOGENICITY OF A POLYVALENT MELANOMA ANTIGEN VACCINE IN HUMANS
    BYSTRYN, JC
    ORATZ, R
    HARRIS, MN
    ROSES, DF
    GOLOMB, FM
    SPEYER, JL
    CANCER, 1988, 61 (06) : 1065 - 1070
  • [22] Long-Term Remission of Malignant Melanoma Stage IV after Antigen-Specific Immunotherapy
    Neumann, Antje
    Karbach, Julia
    Atmaca, Akin
    Jaeger, Elke
    MEDIZINISCHE KLINIK, 2010, 105 (04) : 273 - 275
  • [23] IMPROVED SURVIVAL OF PATIENTS WITH MELANOMA WITH AN ANTIBODY-RESPONSE TO IMMUNIZATION TO A POLYVALENT MELANOMA VACCINE
    MILLER, K
    ABELES, G
    ORATZ, R
    ZELENIUCHJACQUOTTE, A
    CUI, J
    ROSES, DF
    HARRIS, MN
    BYSTRYN, JC
    CANCER, 1995, 75 (02) : 495 - 502
  • [24] LONG-TERM SURVIVAL OF PATIENTS WITH ADVANCED MELANOMA TREATED SECOND LINE WITH IPILIMUMAB
    Lee, D.
    Pericleous, L.
    Lebmeier, M.
    Winn, B.
    Batty, A.
    Nikoglou, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 370 - 370
  • [25] Long-term survival and spontaneous tumour regression in stage IV melanoma: Possible role of adrenalectomy and massive tumour antigen release
    Wantz, M.
    Antonicelli, F.
    Derancourt, C.
    Bernard, P.
    Avril, M. -F.
    Grange, F.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2010, 137 (6-7): : 464 - 467
  • [26] Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha
    Mattila, Kalle
    Raanta, Pirita
    Lahtela, Valtteri
    Pyrhonen, Seppo
    Koskivuo, Ilkka
    Vihinen, Pia
    ANTICANCER RESEARCH, 2018, 38 (11) : 6393 - 6397
  • [27] Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: An immunologic survival model
    Jones, RC
    Kelley, M
    Gupta, RK
    Nizze, JA
    Yee, R
    Leopoldo, Z
    Qi, K
    Stern, S
    Morton, DL
    ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (05) : 437 - 445
  • [28] Uveal melanoma: Long-term survival
    Radivoyevitch, Tomas
    Zabor, Emily C.
    Singh, Arun D.
    PLOS ONE, 2021, 16 (05):
  • [29] DEVELOPMENT OF A POLYVALENT MELANOMA TUMOR-ANTIGEN VACCINE
    BYSTRYN, JC
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1983, 9 (08): : 648 - 649
  • [30] Long-term survival of patients (pts) with advanced melanoma treated with ipilimumab with or without dacarbazine
    Hersh, E.
    Weber, J.
    Powderly, J.
    Pavlik, A.
    Nichol, G.
    Yellin, M.
    Cranmer, L.
    Urba, W.
    O'Day, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345